Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person
Early stages of epithelial-to-mesenchymal transition like...
| Class:Id | Summation:9935131 |
|---|---|
| _displayName | Early stages of epithelial-to-mesenchymal transition like... |
| _timestamp | 2025-01-16 17:33:19 |
| created | [InstanceEdit:9935134] Orlic-Milacic, Marija, 2025-01-13 |
| modified | [InstanceEdit:9935596] Orlic-Milacic, Marija, 2025-01-16 |
| text | Early stages of epithelial-to-mesenchymal transition likely involve post-translational downregulation of CDH1, while later stages of EMT involve transcriptional silencing of CDH1 (Janda et al. 2006). Two E3 ubiquitin ligases have been reported to ubiquitinate CDH1 and promote its degradation. MDM2 (HDM2) was reported to mediate ubiquitin-dependent degradation of CDH1 by the proteasome (Yang et al. 2006; Adhikary et al. 2014; Lu et al. 2015; Wang et al. 2020; Zhao et al. 2020), while CBLL1 (Hakai) was reported to mediated ubiquitin-dependent lysosomal degradation of CDH1 (Fujita et al. 2002; Shen et al. 2008; Chen et al. 2009; Hartsock and Nelson 2012; Smyth et al. 2012; Sako-Kubota et al. 2014; Lu et al. 2018; reviewed in Zhang et al. 2023). |
| (summation) | [Pathway:9766229] Degradation of CDH1 [Homo sapiens] |
| [Change default viewing format] | |
Early stages of epithelial-to-mesenchymal transition like... (9935131)
